The Online Investor

Slideshow Mergers & Acquisitions

By The Online Investor Staff, updated Fri., Feb. 3, 10:49 AM

Slide #32. Biosynex SA Chembio Diagnostics, Inc.

Acquirer: Biosynex SA
Acquiree: Chembio Diagnostics, Inc. (NASDAQ:CEMI)
Details: Biosynex SA ("Biosynex") (EPA: ALBIO), a French market leader specializing in the design and distribution of rapid tests, and Chembio Diagnostics, Inc. ("Chembio") (Nasdaq: CEMI), a leading point-of-care diagnostics company focused on infectious diseases, today announced that the companies have entered into a definitive merger agreement under which Biosynex, through a subsidiary, will acquire Chembio for $0.45 per share, representing a premium of 27% compared to the closing price of Chembio stock on January 30, 2023, in an all-cash transaction valued at $17.2 million.



Open the CEMI Page at The Online Investor »

Company Name: 
Chembio Diagnostics Inc
Website: 
www.chembio.com
Sector: 
Drugs & Pharmaceuticals
Number of ETFs Holding CEMI: 
3
Total Market Value Held by ETFs: 
$671340
Total Market Capitalization: 
$16.00M
% of Market Cap. Held by ETFs: 
4.20%
 

Open the CEMI Page at The Online Investor (in a new window) »

Quotes delayed 20 minutes

Email EnvelopeFree CEMI Email Alerts:
Get SEC Filing Alerts
Get Dividend Alerts

Hold (2.00 out of 4)
0th percentile
(ranked lower than approx. 100% of all stocks covered)

Analysts' Target Price:
CEMI Stock Forecast

Based on Zacks ABR data;
powered by Xignite

Mergers & Acquisitions Page | www.TheOnlineInvestor.com

Copyright © 1998 - 2023, All Rights Reserved
Nothing in The Online Investor is intended to be investment advice, nor does it represent the opinion of, counsel from, or recommendations by BNK Invest Inc. or any of its affiliates, subsidiaries or partners. None of the information contained herein constitutes a recommendation that any particular security, portfolio, transaction, or investment strategy is suitable for any specific person. All viewers agree that under no circumstances will BNK Invest, Inc,. its subsidiaries, partners, officers, employees, affiliates, or agents be held liable for any loss or damage caused by your reliance on information obtained. By visiting, using or viewing this site, you agree to the following Full Disclaimer & Terms of Use and Privacy Policy. Video widget and stock market videos powered by Market News Video. Quote data delayed at least 20 minutes; data powered by Ticker Technologies, and Mergent. Contact The Online Investor; Meet Our Editorial Staff.